Tucumanin, a β-hydroxy-γ-lactone bistetrahydrofuranic acetogenin from Annona cherimolia, is a potent inhibitor of mitochondrial complex I by Barrachina, Isabel et al.
Natural Products and Medicinal Plant Research
Planta Medica
Editor
Prof. Dr. Adolf Nahrstedt
Institut fUr Pharmazeutische Biologie
und Phytoch emie der Universitat
Hittorfstra~e 56
0-48149 Munster
Germany
Fax: +4925183-38341
E-mail: nahrste@uni-muenster.de
Co-Editors
Prof. Dr. W. Sarz, Munster
Prof. Dr. R. Bauer, Graz
Prof. Dr. G. Franz, Regensburg
Prof. Dr. M. Hamburger, Basel
Prof. Dr. I. Khan, Oxford, MS
Editorial AdVisory Board
Y. Asakawa. Tokushima
L. Bohlin, Uppsala
I. Calis, Ankara
S. Canigueral, Barcelona
A. M. Clark, Oxford, MS
O. Guo, Peking
R. Maffei Facino, Milano
S. Habtemariam, London
G. Harnischfeger, Salzgitter
W. Herz, Tallahassee
M. Hesse, Zurich
K. Hostettmann, Lausanne
P. J. Houghton, London
P. Joseph-Nathan, Mexico City
G. Kahl, FrankfurtjM
W. Kreis, Erlangen
U. Matern, Marburg
I. Merfort. Freiburg
S. Nyiredy, Budakalasz
K.-M. Oksman-Caldentey, Espoo
P. Potier, Gif-sur-Yvette
V. Schulz, Berlin
J. F. Verbist, Nantes
E. J.Verspohl, Munster
A. Vlietinck, Antwerp
A. Vollmar, Munchen
H. Vuorela, Helsinki
H. Yamada, Tokio
Reprint
© Georg Thieme Verlag KG
Stuttgart· New York
Georg Thieme Verlag KG
Stuttgart· New York
Rudigerstra~e14
0-70469 Stuttgart
Postfach 3011 20
0-70451 Stuttgart
Thieme New York
333 Seventh Avenue
New York, NY 10001
Tucumanin. a {3-Hydroxy-y-lactone
Bistetrahydrofuranic Acetogenin
from Annona cherimolia, is a Potent
Inhibitor of Mitochondrial Complex I
Isabel Barrachina I, Adriana Neske2, Susana Granell1,
Almudena Bermejo" Nadia Chahboune I, Noureddine EI Aouad l ,
Olga Alvarez2, Alicia Bardon 2, M. Carmen Zafra-Polo 1
Abstract
Anew {3-hydroxy-y-methyl-y-lactone bistetrahydrofuranic aceto-
genin, tucumanin, with the infrequent symmetrical threo/trans/
threo/trans/threo relative configuration at the tetrahydrofuran
rings was isolated from Annona cherimolia (Annonaceae) seeds.
The inhibitory potency on the mitochondrial complex Iof aceto-
genins with this relative configuration (tucumanin and asimicin)
was compared with that shown by the corresponding pairs with
an asymmetrical threo/trans/threo/trans/erythro relative config-
uration (laherradurin/rolliniastatin-2, and itrabin/molvizarin).
All these compounds act as selective inhibitors of mitochondrial
complex I in the 0.18 -1.55 nM range.
"Cherimoya" is an edible fruit from a tropical tree (Annona
cherimolia Mill., Annonaceae) native to Peru that is cultivated
worldwide. In previous chemical studies on the seeds of A.
cherimolia cultivated in an small pseudo-tropical area in the
south of Spain, on the coast of Granada, four monotetrahydro-
furanic (mono-THF) and eleven bistetrahydrofuranic (bis-THF)
acetogenins were isolated [1], [2]. Recently, three new cytotoxic
mono-THF acetogenins, annocherin, annomolin, and annocheri-
molin, were isolated from seeds of "cherimoya" grown in planta-
tions of Southern California [31,14] .
The Annonaceous acetogenins are claimed as potent inhibitors of
NADH:ubiquinone oxidoreductase (complex I) in the mitochon-
drial electron transport chain [5]. Among them, the {3-hydroxy-y-
methyl-y-Iactone acetogenins, a type of acetogenin only isolated
from the seeds of A. cherimolia, are more potent complex I inhi-
bitors than any other natural acetogenin [6]. The high potency of
this class of acetogenins led us to further investigate the compo-
sition of seeds collected in Tucuman (Argentina).
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Fractionation of the methanolic extract furnished 11 known acet-
ogenins (almunequin, asimicin, cherimolin-1, itrabin, laherra-
durin, molvizarin, motrilin, neoannonin, rolliniastatin-2, squa-
mocin, squamocin-B) and a new acetogenin, tucumanin (1). The
molecular weight of 1 was established by the [M+Nar ion ob-
served at m/z = 647.45183 (calcd. 647.44988 for C37HGs07Na) in
the HR-LSI-MS. Absorptions at 204 nm and at 1760 cm- I in the
UV and IR spectra, repectively, are in accordance with the pres-
ence of a saturated y-lactone ring in 1[1] . The 1H-NMR spectrum
and the 20 homo nuclear correlation (lH-IH COSY 45) of 1. prove
the existence of an ABX spin system, characteristic of the three
lactone ring protons of a (3-hydroxy-y-methyl-y-lactone aceto-
genin [7], [8]: H-2 (rx) at {j = 2.58, H-35 ({3) at (5 = 4.19, and H-36
(y) at (5 = 4.49. These protons are correlated in 20 heteronuclear
NMR experiments (HMQC and HMBC) with three methine car-
bons at (5 = 43.7, (573.7, and (582.4, respectively (Fig.1). The rela-
tive configuration of the lactone moiety deduced from the cou-
pling constants, J,,-~ = 5.5 Hz (cis) and J~- y = 1.0 Hz (trans), was
in agreement with that reported by Sibi et al. for the synthetic la-
herradurin [9].
The presence of an rx, rx'-dihydroxylated bis-THF system with the
infrequent symmetrical threo/trans/threo/trans/threo relative
configuration was deduced from IH-13C NMR heteronuclear cor-
relations between the signals at (5 = 3.38 and (5 = 74.0 (two me-
thine alcohol), and between the signals at (5 = 3.81 and 0 = 83.1
(two methine tetrahydrofuran) [lOJ. This system is placed be-
tween C-15 and C-24 based on the fragment ions observed in
the EI-MS (Fig.1). Compound 1 is the first {3-hydroxy-y-methyl
y-lactone adjacent bis-THF acetogenin with a threo/trans/threo/
trans/ threo relative configuration.
In previous studies we have shown that the inhibitory potency of
acetogenins is modulated by several structural factors. Therefore,
it is relevant to compare the inhibitory potency of acetogenins
with this type of configuration (tucumanin, 1 and asimicin, 2)
with that of the corresponding pairs with an asymmetrical
threo/trans/threo/trans/erythro relative configuration (laherra-
durin, 3/rolliniastatin-2, 5, and itrabin, 4/molvizarin, 6). As po-
tency criterion we used the ICso against the integrated NADH oxi-
dase activity of beef heart open submitochondrial particles [5].
[6], [12]. which evaluates the complex I activity in a more phys-
iological environment. Results are shown in Table 1.
The {3-hydroxyacetogenins with a threo/trans/threo/trans/erythro
relative configuration, laherradurin (3) and itrabin (4) (lCso =
0.18 and 0.21 nM, respectively) are more potent inhibitors of the
mitochondrial complex I than the corresponding rx,{3-unsatura-
ted y-Iactone acetogenins, rolliniastatin-2 (5) and molvizarin (6)
(lCso = 0.51 and 1.55 nM, respectively). However, tucumanin (1)
(ICso = 0.57 nM) shows an inverted tendency when compared to
asimicin (2) (lcso = 0.33 nM), both with a threo/trans/threo/
trans/threo relative configuration. Therefore, our data show that,
indeed, the terminal y-methyl-y-Iactone ring and the relative
configuration at the THF system are both relevant structural fac-
tors for a potent inhibition of the mitochondrial complex I, be-
cause of a double binding to the active site of the enzyme to
which both moieties probably contribute.
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Table 1 Inhibitory potency of acetogenins 1- 6
Compound
2 3 4 5 6 rotenone {6]
NADH oxidase 1(50 (nM) 0.57 ± q:07' 0.33 ± 0.03' 0.18 ± 0.02" 0.21 t 0.03' 0.5i ± 0.03' 1.551'0.17' 5.10 ± 0.09
Significant difference compared with rotenone; • P< 0.001.
Material and Methods
Optical rotation (Perkin-Elmer 241 polarimeter), IR spectra (Sa-
tellite FTIR-Mattson 980514 spectrometer), MS (VG Auto Spec Fi-
sons spectrometer), lH_ and 13C-NMR, DEPT, HMBC, HMQC, tH-
1H-COSY (Varian Unity 400 MHz spectrometer) using the solvent
signal as reference (CDCl) at 8 = 7.26 and 77.0). Chromatograph-
ic separations were carried out by column chromatography on si-
lica gel 60 H(5 - 40 ,um, 7336 Merck). Semi preparative HPLC was
carried out on a LiChroCartR 100 RP-18 column (25 x 1 em i. d.,
10,um particle size), flow rate 4.5 mLjmin. using MeOH-H 20-
THF. Analytical TLC was performed on Merck precoated silica
gel 60 F254 plates.
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The fruits of Annona eherimo/ia Mill. ("cherimoya") were collect-
ed at Yerba Buena, Tucuman, Argentina, in February 2000. A
voucher sample (No. 515092) was deposited at the Herbarium
of Instituto Li 110 ofTucuman.
The dried and powdered seeds of cherimoya (350 g) were percolat-
ed with methanol (2 x 3 L). Evaporation of the solvent yielded a
crude MeOH extract (15 g) which was further partitioned between
CH2Cl2 (3 x 100 mL) and H20 (100 mL). The CH2CI2 layer was
washed with water, dried over anhydrous Na2S04, filtered, and
evaporated in vacuum to give 9 g of a solid extract with an aceto-
genin mixture, which was chromatographed on a silica gel 60 H
(315 g) column, using gradients of hexane/EtOAc (90 : 10; 80: 20;
70: 30; 60: 40; 50: 50; 40: 60; 20; 80 and 10: 90) giving eight
fractions (F-I to F-VIII , 250 mL each). Fraction F-IH (hexane/EtOAc
70: 30, 660 mg) was again chromatographed on silica gel 60 H
(23 g) and eluted with CH2CI2/MeOH (95: 5) to give five subfrac-
tions (50 mL each), one of them (F-III]) was applied to semipre-
parative HPLC with MeOH-H20-THF (87: 13: 5) affording neoan-
nonin {12 mg, Rt = 10.8 min, [aI55 : + 16.2° (CHCl ], e 0.8)}; , F-IV
(hexane/EtOAc, 60: 40, 2 g) was chromatographed on silica gel
60 H (70 g) and eluted with CH2CI 2/EtOAc/MeOH (50: 45: 5) to
yield eight subfractions (100 mL each). F-IV5 and F-IV6 by semi-
preparative HPLC with MeOH-H20-THF 80: 20: 5 afforded squa-
mocin {90 mg, R[ = 16.6 min, [aI55: + 14.0° (CHCI], e 0.13), squa-
mocin-B (16 mg, Rr = 8.7 min, [a]55 ; + 27.6 (MeOH, e 0.2) and
motrilin (5 mg, Rr = 14.8 min, [a]b5 : + 10.8' (MeOH, c O.13)}, and
asimicin {2, 5 mg, Rr = 29.4 min, [aI55 : + 11.0U (CHCl], c 0.22),
molvizarin (6, 10 mg, Rr _ 13.9 min, [a155: + 10.0° (CHCI3, e 0.2)
and rolliniastatin-2 (5, 5 mg, Rt = 11.3 min, [a]55 : + 12.8' (CHCl3,
e 0.26 )), respectively. F-VI (hexane/EtOAc, 40: 60, 500 mg) was
chromatographed on silica gel (18 g) and eluted with CH2Cl2/
EtOAc/MeOH (60: 13: 10) to give four subfractions (75 mL each).
One of them (F-VI2 ) was applied to semipreparative HPLC with
MeOH-H20-THF (80: 20: 5) affording cherimolin-1 {IS mg,
R1 = 8.9 min, [a]55 : +64.0° (MeOH, e 0.3) and almunequin
(5 mg, R, = 5.8 min, laJb5: + 13.5' (CHCI3, c 0.14)}. F-VIII (hex-
ane/HOAc, 10: 90, 250 mg) was chromatographed on silica gel
(9 g) and eluted with CH2Cl2/HOAc/MeOH (10: 85: 5) to give
three subfractions (50 mL each). F-VlII 2 was applied to semipre-
parative HPLC with MeOH-H20-THF (80: 20: 5) affording itrabin
{4. 40 mg, Rr = 2.1 min. [aI55: + 21 .0' (MeOH, c 0.2), laherradurin
(3,60 mg, Rt = 3.5 min, [a]55 : + 21.0° (MeOH, e0.09) and tucuma-
nin (1,11 mg, Rr = 4.2 min)}.
Tucumanin (1): waxy compound, [a]55: + 1.5- (EtOH, e 0.8); UV
(EtOH): A max (log £) = 204 nm (3.8). IR (film ): Vmax = 3360,
2923,2853,1760,1465,1052 cm- t• HR-LSI-MS: m/z = 647.45183
[M + Na]+ (caled. for C37H6807Na: 647.44988). EI-MS, IH-NMR
(400 MHz). and I3C-NMR (100 MHz), see Fig.1.
The inhibitory potency of acetogenins as complex r inhibitors
was assayed using submitochondrial particles from beef heart
as previously reported [5], [11], [12]. NADH oxidase activity was
measured as the aerobic oxidation of75 ,uM NADH in the absence
of external quinone substrates and other inhibitors of the re-
spiratory chain. Rotenone (Sigma-Aldrich St. Louis, MO, USA)
was used as the positive control. Data from four titrations were
used to determine the statistic means and the standard devia-
Letter ... Planta Med 2004; 70: 866 - 868
tions. Significance of differences was evaluated by the Student's
t test, with P< 0.001 being regarded as significant.
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